New drug trial aims to stop dialysis patients from crashing
NCT ID NCT05297786
Summary
This study is testing if a drug called lanadelumab can prevent severe drops in blood pressure during dialysis. It involves 28 adults on regular dialysis who frequently experience this problem with symptoms like dizziness and cramps. Researchers will compare the drug to a placebo to see if it helps maintain more stable blood pressure during treatment sessions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMODIALYSIS COMPLICATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.